Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:33:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding and operating status notice displayed on the page, eliminating the banner that previously warned users about updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:51:48.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No additions or deletions detected on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:45:44.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Page version updated to v3.2.0 - Added government operating-status notice and guidance on where to check status - Removed a specific genetic cancer resource entry (Thyroid gland undifferentiated carcinoma)
    Difference
    4%
    Check dated 2025-10-06T04:57:01.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Page version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:56:51.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed; overall, core content remains focused on the version bump with no other substantive data changes.
    Difference
    0.2%
    Check dated 2025-09-14T18:58:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.